XXXX Abnormalities in Current Clinical Practice: Frequency, Causes, Severity and Management.

@entity1 @entity972 @entity1369 @entity177 @entity8598 @entity916 @entity6564 @entity1371 @entity4144
OBJECTIVE: We aimed to investigate the prevalence and etiology of @entity972 abnormalities ( @entity1371 and @entity4144 ) and management approaches for hospitalized @entity1 . SUBJECTS AND METHODS: Over a 4-month period, all hospitalized @entity1 at Hacettepe University Medical Faculty Hospitals who underwent at least one measurement of serum @entity972 during hospitalization were included. Data on serum levels of electrolytes, demographic characteristics, cause(s) of hospitalization, medications, etiology of @entity972 abnormality and treatment approaches were obtained from the hospital records. RESULTS: Of the 9,045 hospitalized @entity1 , 1,265 (14.0%) had a serum @entity972 abnormality; 604 (6.7%) @entity1 had @entity1371 and 661 (7.30%) had @entity4144 . In the @entity8598 @entity1 , the most important reasons were gastrointestinal losses in 555 (91.8%) @entity1 and renal losses in 252 (41.7%) @entity1 . The most frequent treatment strategies were correcting the underlying cause and replacing the @entity972 deficit. Of the 604 @entity8598 @entity1 , 319 (52.8%) were normokalemic at hospital discharge. The most common reason for @entity4144 was treatment with @entity916 -angiotensin- @entity1369 system blockers in 228 (34.4%) @entity1 , followed by @entity177 in 191 (28.8%). Two hundred and ninety-eight (45.0%) @entity1 were followed without any specific treatment. Of the 661 @entity6564 @entity1 , 324 (49.0%) were normokalemic at hospital discharge. CONCLUSION: This study showed a high prevalence of @entity972 imbalance among hospitalized @entity1 . Although most of the @entity972 abnormalities were mild/moderate, approximately half of the @entity1 treated for @entity1371 or @entity4144 were discharged from the hospital with ongoing dyskalemia.    2015 S. Karger AG, Basel.
